AZTR News

Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement

Form 8-K

Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders

Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

Form 8-K

Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash

Azitra, Inc. to Present at BIO Investment & Growth Summit

Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting

Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American